smh and wa business articles

http://www.smh.com.au/news/Business/Visiomed-Clinical-Cell-Culture-to-merge/2007/10/10/1191695964138.html

and

http://www.wabusinessnews.com.au/en-story.php?/1/57407/Visiomed-C3-announce-merger-plans

Deal is good... even though the ratio is 7:5 VSG will have a controlling 53% stake

With the contacts, business structure and the obvious support CCE has for VSGs product
plus
With the cash, distributors and patents that VSG has

The markets open up a little more and plans accelerate

CCE and VSG seem to have been talking for a while now. both sides seem happy with the deal, no hostilities at all

i think it is good... todays price action (imo) was not good and not bad still sizing up the pros/cons of the merger